TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

QNB16.68-1.3%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10

premargin

Fundamentals-first equity research for GCC markets

Screener Disclosures Contact Us Privacy Policy Terms of Use

LinkedIn X Instagram

Research updates, no noise

you@example.com Research updates, no noise

you@example.com

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

QNB16.68-1.3%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10

-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

QNB16.68-1.3%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Gulf Pharmaceutical Industries Management Discussion and Analysis Report for the Period Ended December 31,2025 | premargin

Gulf Pharmaceutical Industries Management Discussion and Analysis Report for the Period Ended December 31,2025

·ADX·Financial Reports | Management Discussion and Analysis Report·March 27, 2026·View on exchange

AI Summary

Reported 2025 revenue of 1,075.5 million AED from continuing operations, an 8.4% increase year-over-year, while total net profit rose to 173.3 million AED.
Achieved a significant reduction in debt, with total interest-bearing debt declining by 649.4 million AED to a closing balance of 263.8 million AED.

Recognized a one-time capital gain of 111.2 million AED from the divestment of Zahrat Al Rawdah Pharmacies and accepted a binding offer to sell further retail and distribution assets in the UAE and Oman.

Expanded the product portfolio through the launch of 14 new products in the UAE and secured 25 global regulatory approvals to support international growth.

Loading PDF preview...

Attachments

Gulf Pharmaceutical Industries Management Discussion and Analysis Report for the Period Ended December 31,2025

Gulf Pharmaceutical Industries